{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-027245","form_type":"8-K","ticker":"AARD","cik":"0001774857","company_name":"Aardvark Therapeutics, Inc.","filed_at":"2025-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.812178+00:00","generated_at":"2026-05-26T21:29:49.715512+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aardvark Therapeutics completes IPO; issues 5.888M shares at $16.00, raises $94.2M gross","bullets":["IPO of 5,888,000 shares at $16.00 per share completed on Feb 14, 2025.","Gross proceeds $94.2M before underwriting discounts and commissions.","Amended certificate authorizes 490M common shares and 10M preferred shares.","Amended bylaws establish classified board, stockholder proposal procedures, and exclusive forum provision.","Common stock trades on Nasdaq under ticker AARD."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-027245","json":"https://secwatch.observer/filing/0001193125-25-027245.json","markdown":"https://secwatch.observer/filing/0001193125-25-027245.md","text":"https://secwatch.observer/filing/0001193125-25-027245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/0001193125-25-027245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/d890894d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T21:29:49.715512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}